AVAH
Aveanna Healthcare Holdings Inc.
Medical - Care Facilities
Market Cap$1.46B
5Y Perf.-40.6%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
AVAH vs DBVT vs ALKS vs PNTG
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1712.35T
5Y Perf.-69.4%
ALKS
Alkermes plc
Biotechnology
Market Cap$5.90B
5Y Perf.+60.9%
PNTG
The Pennant Group, Inc.
Medical - Care Facilities
Market Cap$1.24B
5Y Perf.-11.6%
AVAH vs DBVT vs ALKS vs PNTG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AVAH | DBVT | ALKS | PNTG |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Biotechnology | Biotechnology | Medical - Care Facilities |
| Market Cap | $1.46B | $1712.35T | $5.90B | $1.24B |
| Revenue (TTM) | $2.43B | $0.00 | $1.56B | $1.02B |
| Net Income (TTM) | $225M | $-168M | $153M | $30M |
| Gross Margin | 33.1% | — | 65.4% | 11.1% |
| Operating Margin | 10.9% | — | 12.3% | 5.6% |
| Forward P/E | 12.0x | — | 24.8x | 27.0x |
| Total Debt | $1.34B | $22M | $70M | $453M |
| Cash & Equiv. | $193M | $194M | $1.12B | $17M |
AVAH vs DBVT vs ALKS vs PNTG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AVAH
DBVT
ALKS
PNTG
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Aveanna Healthcare … (AVAH) | 100 | 59.4 | -40.6% |
| DBV Technologies S.… (DBVT) | 100 | 30.6 | -69.4% |
| Alkermes plc (ALKS) | 100 | 160.9 | +60.9% |
| The Pennant Group, … (PNTG) | 100 | 88.4 | -11.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVAH vs DBVT vs ALKS vs PNTG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: AVAH and PNTG are tied at the top with 2 categories each — the right choice depends on your priorities. The Pennant Group, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. DBVT and ALKS also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
AVAH
Aveanna Healthcare Holdings Inc.
The Value Play
AVAH has the current edge in this matchup, primarily because of its strength in value and efficiency.
- Lower P/E (12.0x vs 27.0x)
- 12.4% ROA vs DBVT's -89.0%
Best for: value and efficiency
DBVT
DBV Technologies S.A.
The Momentum Pick
DBVT is the clearest fit if your priority is momentum.
- +110.4% vs ALKS's +16.5%
Best for: momentum
ALKS
Alkermes plc
The Defensive Pick
ALKS is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
- Beta 1.06, current ratio 3.55x
- 9.8% margin vs DBVT's 0.3%
Best for: sleep-well-at-night and defensive
PNTG
The Pennant Group, Inc.
The Income Pick
PNTG is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 0.79
- Rev growth 36.3%, EPS growth 18.3%, 3Y rev CAGR 26.0%
- 136.8% 10Y total return vs ALKS's -11.0%
- 36.3% revenue growth vs DBVT's -100.0%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PNTG | 36.3% revenue growth vs DBVT's -100.0% |
| Value | AVAH | Lower P/E (12.0x vs 27.0x) |
| Quality / Margins | ALKS | 9.8% margin vs DBVT's 0.3% |
| Stability / Safety | PNTG | Beta 0.79 vs AVAH's 1.40, lower leverage |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | DBVT | +110.4% vs ALKS's +16.5% |
| Efficiency (ROA) | AVAH | 12.4% ROA vs DBVT's -89.0% |
AVAH vs DBVT vs ALKS vs PNTG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
FY 2025
FY 2025
AVAH vs DBVT vs ALKS vs PNTG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLALKSLAGGINGDBVT
Who Leads Where
ALKS leads in 2 of 6 categories
PNTG leads 2 • AVAH leads 1 • DBVT leads 0 • 1 tied
Explore the data ↓DBVTDBV Technologies S.A.
0leads
AVAHAveanna Healthcare Ho…
1leads
PNTGThe Pennant Group, In…
2leads
ALKSAlkermes plc
2leads
6 Total Categories
CATEGORYLEADERvs PNTGvs AVAHMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ALKS4/6
Valuation MetricsMultiples, price ratios, and targets
AVAH4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ALKS5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
PNTG2/2
Analyst OutlookRatings, price targets, and dividends
PNTG1/1
Income & Cash Flow (Last 12 Months)
ALKS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAH and DBVT operate at a comparable scale, with $2.4B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to PNTG's 3.0%. On growth, PNTG holds the edge at +36.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $0 | $1.6B | $1.0B |
| EBITDAEarnings before interest/tax | $289M | -$112M | $212M | $66M |
| Net IncomeAfter-tax profit | $225M | -$168M | $153M | $30M |
| Free Cash FlowCash after capex | $126M | -$151M | $392M | $47M |
| Gross MarginGross profit ÷ Revenue | +33.1% | — | +65.4% | +11.1% |
| Operating MarginEBIT ÷ Revenue | +10.9% | — | +12.3% | +5.6% |
| Net MarginNet income ÷ Revenue | +9.2% | — | +9.8% | +3.0% |
| FCF MarginFCF ÷ Revenue | +5.2% | — | +25.1% | +4.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.4% | — | +28.2% | +36.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.9% | +91.5% | -4.1% | +9.1% |
ALKS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
AVAH leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 6.6x trailing earnings, AVAH trades at a 84% valuation discount to PNTG's 42.5x P/E. On an enterprise value basis, AVAH's 9.0x EV/EBITDA is more attractive than PNTG's 28.0x.
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Market CapShares × price | $1.5B | $1712.35T | $5.9B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $1712.35T | $4.9B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | 6.61x | -0.76x | 24.76x | 42.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.96x | — | — | 26.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.23x |
| EV / EBITDAEnterprise value multiple | 9.04x | — | 17.25x | 27.97x |
| Price / SalesMarket cap ÷ Revenue | 0.60x | — | 4.00x | 1.31x |
| Price / BookPrice ÷ Book value/share | 7.67x | 0.66x | 3.28x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 11.63x | — | 12.28x | 47.16x |
AVAH leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
ALKS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
AVAH delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVAH's 6.91x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs PNTG's 3/9, reflecting strong financial health.
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.5% | -130.2% | +8.8% | +8.4% |
| ROA (TTM)Return on assets | +12.4% | -89.0% | +5.4% | +3.5% |
| ROICReturn on invested capital | +15.1% | — | +18.9% | +5.6% |
| ROCEReturn on capital employed | +18.6% | -145.7% | +14.2% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 3 |
| Debt / EquityFinancial leverage | 6.91x | 0.13x | 0.04x | 1.21x |
| Net DebtTotal debt minus cash | $1.2B | -$172M | -$1.0B | $436M |
| Cash & Equiv.Liquid assets | $193M | $194M | $1.1B | $17M |
| Total DebtShort + long-term debt | $1.3B | $22M | $70M | $453M |
| Interest CoverageEBIT ÷ Interest expense | 1.79x | -189.82x | 32.30x | 16.52x |
ALKS leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — AVAH and PNTG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs ALKS's +16.5%. The 3-year compound annual growth rate (CAGR) favors AVAH at 89.5% vs ALKS's 4.6% — a key indicator of consistent wealth creation.
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | +4.9% | +25.3% | +28.4% |
| 1-Year ReturnPast 12 months | +44.0% | +110.4% | +16.5% | +28.7% |
| 3-Year ReturnCumulative with dividends | +580.4% | +19.7% | +14.5% | +204.1% |
| 5-Year ReturnCumulative with dividends | -39.8% | -69.1% | +60.9% | -6.9% |
| 10-Year ReturnCumulative with dividends | -42.2% | -87.0% | -11.0% | +136.8% |
| CAGR (3Y)Annualised 3-year return | +89.5% | +6.2% | +4.6% | +44.9% |
Evenly matched — AVAH and PNTG each lead in 2 of 6 comparable metrics.
Risk & Volatility
PNTG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PNTG is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than AVAH's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PNTG currently trades 99.7% from its 52-week high vs AVAH's 67.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 1.26x | 1.06x | 0.79x |
| 52-Week HighHighest price in past year | $10.32 | $26.18 | $36.60 | $35.84 |
| 52-Week LowLowest price in past year | $3.73 | $7.53 | $25.17 | $21.73 |
| % of 52W HighCurrent price vs 52-week peak | +67.2% | +76.3% | +96.7% | +99.7% |
| RSI (14)Momentum oscillator 0–100 | 53.4 | 48.1 | 60.2 | 62.5 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 252K | 2.3M | 245K |
PNTG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
PNTG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AVAH as "Hold", DBVT as "Buy", ALKS as "Buy", PNTG as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 9.2% for PNTG (target: $39).
| Metric | AVAHAveanna Healthcar… | DBVTDBV Technologies … | ALKSAlkermes plc | PNTGThe Pennant Group… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $11.00 | $46.33 | $44.00 | $39.00 |
| # AnalystsCovering analysts | 12 | 15 | 28 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.5% | 0.0% |
PNTG leads this category, winning 1 of 1 comparable metric.
Key Takeaway
ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PNTG leads in 2 (Risk & Volatility, Analyst Outlook). 1 tied.
Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...
AVAH vs DBVT vs ALKS vs PNTG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AVAH or DBVT or ALKS or PNTG a better buy right now?
For growth investors, The Pennant Group, Inc.
(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 6x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVAH or DBVT or ALKS or PNTG?
On trailing P/E, Aveanna Healthcare Holdings Inc.
(AVAH) is the cheapest at 6. 6x versus The Pennant Group, Inc. at 42. 5x. On forward P/E, Aveanna Healthcare Holdings Inc. is actually cheaper at 12. 0x.
03Which is the better long-term investment — AVAH or DBVT or ALKS or PNTG?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.
9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: PNTG returned +136. 8% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVAH or DBVT or ALKS or PNTG?
By beta (market sensitivity over 5 years), The Pennant Group, Inc.
(PNTG) is the lower-risk stock at 0. 79β versus Aveanna Healthcare Holdings Inc. 's 1. 40β — meaning AVAH is approximately 76% more volatile than PNTG relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVAH or DBVT or ALKS or PNTG?
By revenue growth (latest reported year), The Pennant Group, Inc.
(PNTG) is pulling ahead at 36. 3% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVAH or DBVT or ALKS or PNTG?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVAH or DBVT or ALKS or PNTG more undervalued right now?
On forward earnings alone, Aveanna Healthcare Holdings Inc.
(AVAH) trades at 12. 0x forward P/E versus 27. 0x for The Pennant Group, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.
08Which pays a better dividend — AVAH or DBVT or ALKS or PNTG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AVAH or DBVT or ALKS or PNTG better for a retirement portfolio?
For long-horizon retirement investors, The Pennant Group, Inc.
(PNTG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 79), +136. 8% 10Y return). Both have compounded well over 10 years (PNTG: +136. 8%, AVAH: -42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVAH and DBVT and ALKS and PNTG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AVAH is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; PNTG is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.